BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 13659105)

  • 1. [Protective action of lysergic acid ethylamide (LAE-32) on behavior changes & on histological lesions of the central nervous system induced in mice by chronic treatment with 5-hydroxytryptamine].
    SORIANI S; FAVALE E
    Sist Nerv; 1959; 11(1):13-21. PubMed ID: 13659105
    [No Abstract]   [Full Text] [Related]  

  • 2. [Histological changes of the central nervous system experimentally induced by chronic treatment with 5-hydroxytryptamine; protective effects of prophylactic administration of L.S.D].
    SACCHI U; BRUSA A; SORIANI S
    Sist Nerv; 1957; 9(4):230-5. PubMed ID: 13495594
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lesions of the central nervous system in Carassius auratus caused by serotonin and the protective action of lysergic acid diethylamide].
    BRUSA A; GIANNIOTTI G; SACCHI U
    Boll Soc Ital Biol Sper; 1956 Jun; 32(6):438-41. PubMed ID: 13374116
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of serotonin and lysergic acid diethylamide (LSD 25) on excitability of nervous centers].
    CHAUCHARD P; MAZOUE H
    C R Seances Soc Biol Fil; 1957; 151(3):463-4. PubMed ID: 13480003
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction of serotonin and lysergic acid diethylamide (LSD) in the central nervous system.
    SHORE PA; SILVER SL; BRODIE BB
    Experientia; 1955 Jul; 11(7):272-3. PubMed ID: 13241495
    [No Abstract]   [Full Text] [Related]  

  • 7. A central nervous system effect of a nonhallucinatory lysergic acid derivative.
    SPIRTES MA; GUTH PS; POLLEY EH
    Experientia; 1958 Nov; 14(11):428. PubMed ID: 13609622
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of lysergic acid diethylamide, 5-hydroxytryptamine, and related compounds on the liver fluke, Fasciola hepatica.
    MANSOUR TE
    Br J Pharmacol Chemother; 1957 Dec; 12(4):406-9. PubMed ID: 13489165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological trials concerning the mechanism of convulsions due to pure oxygen under pressure in mice].
    LABORIT H; BROUSSOLLE B; PERRIMOND-TROUCHET R
    J Physiol (Paris); 1957 Nov; 49(5):953-62. PubMed ID: 13514634
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of monoethylamide (LAE) and diethylamide (LSD) of lysergic acid on behavior of mouse with imino-beta, beta-dipropionitrile induced circular movement].
    WIDLOCHER D; NAKAJIMA H; THUILLIER J
    C R Seances Soc Biol Fil; 1957; 151(4):668-70. PubMed ID: 13489946
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of serotonin, phenothiazine derivatives, steroids, and tranquilizing agents on the electroencephalogram of rabbits poisoned by lysergic acid diethylamide. I. Action on chronic lysergic acid diethylamide poisoning].
    PIERRE R
    C R Seances Soc Biol Fil; 1957; 151(5):890-2. PubMed ID: 13500688
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of isonicotinic acid hydrazide on the central action of reserpine and 5-hydroxytryptamine].
    BESENDORF H; PLETSCHER A
    Helv Physiol Pharmacol Acta; 1956; 14(4):383-90. PubMed ID: 13405359
    [No Abstract]   [Full Text] [Related]  

  • 13. [Some observations on the action of massive doses of 5-hydroxytryptamine on the central nervous system].
    MANTEGAZZINI P
    Boll Soc Ital Biol Sper; 1956; 32(7-8):839-41. PubMed ID: 13404167
    [No Abstract]   [Full Text] [Related]  

  • 14. [Influence of serotonin inhibitors and derivatives of phenylethylamine on serotonin-induced psychomotor depression in mice].
    Fischer E; Saavedra JM; Smolovich J
    C R Seances Soc Biol Fil; 1968; 162(8):1623-4. PubMed ID: 4238204
    [No Abstract]   [Full Text] [Related]  

  • 15. [Psychopathological experiences with the combined action of lysergic acid mono- & diethylamide (LAE-32, LSD-25)].
    CALLIERI B; RAVETTA M
    Riv Sper Freniatr Med Leg Alien Ment; 1957 Jul; 81(2):267-313. PubMed ID: 13466954
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative edematigenous action in vitro of 5-hydroxytryptamine & histamine on central nervous tissue].
    GOMIRATO G; ZANALDA A
    Arch Sci Med (Torino); 1958 Sep; 106(3):323-5. PubMed ID: 13584109
    [No Abstract]   [Full Text] [Related]  

  • 17. The antagonism of the vascular effects of 5-hydroxytryptamine by BOL 148 and sodium salicylate in the human subject.
    GLOVER WE; MARSHALL RJ; WHELAN RF
    Br J Pharmacol Chemother; 1957 Dec; 12(4):498-503. PubMed ID: 13489181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Teratogenic action of LSD-25 on the central nervous system in mouse fetuses].
    Araszkiewicz H; Bartel H
    Folia Morphol (Warsz); 1972; 31(4):565-74. PubMed ID: 4539123
    [No Abstract]   [Full Text] [Related]  

  • 19. A review of the neurophysiological effects of lysergic acid diethylamide (LSD) and other phychotomimetic agents.
    EVARTS EV
    Ann N Y Acad Sci; 1957 Mar; 66(3):479-95. PubMed ID: 13425237
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental study of some effects of 5-hydroxytryptamine on the central nervous system of rabbits].
    BARUCCI M
    Rass Studi Psichiatr; 1956; 45(5):893-8. PubMed ID: 13420490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.